The metastasis-associated gene Prl-3 is a p53 target involved in cell-cycle regulation

Shashwati Basak1, Suzanne B R Jacobs, Adam J Krieg

  • 1Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA.

Molecular Cell
|May 13, 2008
PubMed

Insights

Prl-3, a gene induced by the tumor suppressor p53, acts as a crucial cell-cycle regulator. Its dual role in cell-cycle progression and cancer progression offers new therapeutic insights.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • The p53 tumor suppressor is critical in preventing cancer by regulating genes for cell-cycle arrest and apoptosis.
  • Prl-3 (phosphatase of regenerating liver-3) has been linked to cancer metastasis due to its overexpression in colorectal cancer and promotion of cell invasiveness.

Purpose of the Study:

  • To identify Prl-3 as a p53-inducible gene.
  • To elucidate the role of Prl-3 in cell-cycle regulation and cancer progression, beyond its previously known role in metastasis.

Main Methods:

  • Identification of Prl-3 as a p53 target gene.
  • Investigation of Prl-3's function in cell-cycle regulation through overexpression and attenuation studies.
  • Analysis of signaling pathways involved, including PI3K-Akt.

Main Results:

  • Prl-3 is confirmed as a p53-inducible gene.
  • Prl-3 overexpression induces G1 cell-cycle arrest downstream of p53, mediated by a PI3K-Akt feedback loop.
  • Reduced Prl-3 expression also causes cell-cycle arrest, indicating its importance in normal cell-cycle progression.

Conclusions:

  • Prl-3 exhibits dose-dependent functions in regulating cell-cycle progression, acting as both a positive and negative regulator.
  • These findings reveal novel insights into Prl-3's multifaceted role in cancer development and progression.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...